Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Steroid for Post-ACDF Dysphagia
NCT04717713Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Feb 2021
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of triamcinolone in dysphagia (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Pharyngeal pressure (High Resolution Impedance Manometry parameters). Started Feb 2021; status: completed.
02
Drugs
triamcinolone
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT04717713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04717713.